John B Goodman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John B Goodman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John B Goodman. John B Goodman is Sr VP & CTIO in ENTEGRIS INC ($ENTG) and Sr. VP, Mgng Dir-Fuel Cells in ENTEGRIS INC ($ENTG) and Director in Proto Labs Inc ($PRLB).
Latest Insider Trading Transactions of John B Goodman
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2021 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,520 | 0 | 14,106 | 12.6 K to 14.1 K (+12.08 %) |
Mar 03 2021 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 151.19 | 1,000 | 151,185 | 12,586 | 13.6 K to 12.6 K (-7.36 %) |
Aug 26 2020 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 132.75 | 1,000 | 132,746 | 13,586 | 14.6 K to 13.6 K (-6.86 %) |
May 21 2020 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,197 | 0 | 14,586 | 13.4 K to 14.6 K (+8.94 %) |
May 17 2019 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,311 | 0 | 13,389 | 12.1 K to 13.4 K (+10.85 %) |
May 17 2019 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,311 | 0 | 13,389 | 12.1 K to 13.4 K (+10.85 %) |
Sep 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 70.00 | 536 | 37,520 | 0 | |
Sep 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 62.68 | 577 | 36,166 | 0 | |
Sep 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 162.95 | 1,113 | 181,365 | 12,078 | 13.2 K to 12.1 K (-8.44 %) |
Sep 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 70.00 | 536 | 37,520 | 13,191 | 12.7 K to 13.2 K (+4.24 %) |
Sep 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 62.68 | 577 | 36,166 | 12,655 | 12.1 K to 12.7 K (+4.78 %) |
Jun 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 70.00 | 536 | 37,520 | 536 | |
Jun 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 62.68 | 577 | 36,166 | 577 | |
Jun 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 130.85 | 400 | 52,340 | 12,078 | 12.5 K to 12.1 K (-3.21 %) |
Jun 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 131.87 | 713 | 94,020 | 12,478 | 13.2 K to 12.5 K (-5.41 %) |
Jun 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 70.00 | 536 | 37,520 | 13,191 | 12.7 K to 13.2 K (+4.24 %) |
Jun 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 62.68 | 577 | 36,166 | 12,655 | 12.1 K to 12.7 K (+4.78 %) |
Mar 16 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 70.00 | 537 | 37,590 | 1,072 | |
Mar 16 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 62.68 | 577 | 36,166 | 1,154 | |
Mar 16 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 122.71 | 1,114 | 136,700 | 10,514 | 11.6 K to 10.5 K (-9.58 %) |
Mar 16 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 70.00 | 537 | 37,590 | 11,628 | 11.1 K to 11.6 K (+4.84 %) |
Mar 16 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 62.68 | 577 | 36,166 | 11,091 | 10.5 K to 11.1 K (+5.49 %) |
May 22 2017 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,586 | 0 | 10,514 | 8.9 K to 10.5 K (+17.76 %) |
May 23 2016 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,665 | 0 | 8,928 | 7.3 K to 8.9 K (+22.92 %) |
Mar 09 2016 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 1,000 | 4,270 | 500 | |
Mar 09 2016 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 73.56 | 1,000 | 73,560 | 7,263 | 8.3 K to 7.3 K (-12.10 %) |
Mar 09 2016 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 1,000 | 4,270 | 8,263 | 7.3 K to 8.3 K (+13.77 %) |
Oct 05 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 67.00 | 100 | 6,700 | 7,263 | 7.4 K to 7.3 K (-1.36 %) |
Oct 05 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 65.78 | 400 | 26,313 | 7,363 | 7.8 K to 7.4 K (-5.15 %) |
Jul 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 500 | 2,135 | 1,500 | |
Jul 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 67.50 | 500 | 33,750 | 7,763 | 8.3 K to 7.8 K (-6.05 %) |
Jul 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 500 | 2,135 | 8,263 | 7.8 K to 8.3 K (+6.44 %) |
May 22 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | A | 31.08 | 1,609 | 50,008 | 1,609 | |
May 22 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 715 | 0 | 7,763 | 7 K to 7.8 K (+10.14 %) |
Apr 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 500 | 2,135 | 2,000 | |
Apr 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 69.76 | 500 | 34,878 | 7,048 | 7.5 K to 7 K (-6.62 %) |
Apr 01 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 500 | 2,135 | 7,548 | 7 K to 7.5 K (+7.09 %) |
Mar 20 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 4.27 | 500 | 2,135 | 2,500 | |
Mar 20 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 69.40 | 500 | 34,700 | 7,048 | 7.5 K to 7 K (-6.62 %) |
Mar 20 2015 | PRLB | Proto Labs Inc | Goodman John B | Director | Buy | M | 4.27 | 500 | 2,135 | 7,548 | 7 K to 7.5 K (+7.09 %) |
Sep 01 2005 | ENTG | ENTEGRIS INC | Goodman John B | Sr VP & CTIO | Grant | A | 0.00 | 834 | 0 | 211,956 | 211.1 K to 212 K (+0.40 %) |
Aug 12 2005 | ENTG | ENTEGRIS INC | Goodman John B | Sr VP & CTIO | Grant | A | 0.00 | 75,000 | 0 | 211,122 | 136.1 K to 211.1 K (+55.10 %) |
Aug 03 2005 | ENTG | ENTEGRIS INC | Goodman John B | Sr. VP, Mgng Dir-Fu ... | Option Exercise | S | 5.90 | 3,000 | 17,700 | 32,500 | |
Jul 01 2005 | ENTG | ENTEGRIS INC | Goodman John B | Sr. VP, Mgng Dir-Fu ... | Option Exercise | S | 5.90 | 3,000 | 17,700 | 35,500 | |
Jun 13 2005 | ENTG | ENTEGRIS INC | Goodman John B | Sr. VP, Mgng Dir-Fu ... | Option Exercise | S | 5.90 | 6,000 | 35,400 | 38,500 | |
Apr 04 2005 | ENTG | ENTEGRIS INC | Goodman John B | Sr. VP, Mgng Dir-Fu ... | Option Exercise | S | 5.90 | 3,000 | 17,700 | 44,500 |
Page: 1